A randomized controlled study for the treatment of depression by regulating circadian rhythm with Sini San

注册号:

Registration number:

ITMCTR1900002301

最近更新日期:

Date of Last Refreshed on:

2019-04-23

注册时间:

Date of Registration:

2019-04-23

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

四逆散调节昼夜节律治疗抑郁症的临床研究

Public title:

A randomized controlled study for the treatment of depression by regulating circadian rhythm with Sini San

注册题目简写:

English Acronym:

研究课题的正式科学名称:

四逆散调节昼夜节律治疗抑郁症的临床研究

Scientific title:

A randomized controlled study for the treatment of depression by regulating circadian rhythm with Sini San

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR1900022700 ; ChiMCTR1900002301

申请注册联系人:

张瑞环

研究负责人:

陈钧

Applicant:

Zhang Ruihuan

Study leader:

Chen Jun

申请注册联系人电话:

Applicant telephone:

+86 18220902457

研究负责人电话:

Study leader's telephone:

+86 15991658129

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2216153741@qq.com

研究负责人电子邮件:

Study leader's E-mail:

chj2002819@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

陕西省西安市莲湖区西华门2号

研究负责人通讯地址:

陕西省西安市西华门2号

Applicant address:

2 Xihuamen, Lianhu District, Xi'an, Shaanxi

Study leader's address:

2 Xihuamen, Lianhu District, Xi'an, Shaanxi

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

陕西省中医医院

Applicant's institution:

Shaanxi Traditional Chinese Medicine Hospital

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

(2019)伦审第(06)号

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

陕西省中医药研究院、陕西省中医医院伦理委员会

Name of the ethic committee:

Shaanxi Academy of Traditional Chinese Medicine and Ethics Committee of Shaanxi Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2019/3/19 0:00:00

伦理委员会联系人:

赵鸣

Contact Name of the ethic committee:

Zhao Ming

伦理委员会联系地址:

陕西省西安市西华门2号

Contact Address of the ethic committee:

2 Xihuamen, Lianhu District, Xi'an, Shaanxi

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 029-87251691

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

陕西省中医医院

Primary sponsor:

Shaanxi Traditional Chinese Medicine Hospital

研究实施负责(组长)单位地址:

陕西省西安市西华门2号

Primary sponsor's address:

2 Xihuamen, Lianhu District, Xi'an, Shaanxi

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西省

市(区县):

西安市

Country:

China

Province:

Shaanxi

City:

Xi’an

单位(医院):

陕西省中医医院

具体地址:

莲湖区西华门2号

Institution
hospital:

Shaanxi Traditional Chinese Medicine Hospital

Address:

2 Xihuamen, Lianhu District

经费或物资来源:

陕西省科技厅

Source(s) of funding:

Science and technology department of shaanxi province

研究疾病:

抑郁症

研究疾病代码:

Target disease:

depression

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

通过临床实验,与西药组对比,观察四逆散调节昼夜节律对抑郁障碍的影响,为进一步临床研究提供依据。

Objectives of Study:

Through clinical experiments and comparison with the western medicine group, the effects of si ni San on the regulation of circadian rhythm on depressive disorder were observed, providing a basis for further clinical research.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)符合诊断标准; (2)体格检查及相关实验室检查排除躯体疾病引起的抑郁; (3)夜间在床时间平均7小时; (4)患者自愿参加临床试验,并签署知情同意书者; (5)年龄 18-65 岁之间; (6)初中以上文化者。

Inclusion criteria

(1)Meet diagnostic criteria; (2)Physical examination and related laboratory examination exclude depression caused by physical diseases; (3)Average time in bed at night is 7 hours; (4)Patients voluntarily participate in clinical trials and sign the informed consent; (5)Aged 18 to 65 years; (6)Junior high school education or above.

排除标准:

(1)合并躯体疾病或脑器质性疾病者; (2)近两周内曾使用或者正使用任何抗抑郁药物及抗精神病药物者; (3)排除由酒精或咖啡、浓茶等生活因素所致的情绪障碍者; (4)妊娠及哺乳期妇女,月经期妇女; (5)一个月内参加其它临床试验者; (6)有自杀倾向者。

Exclusion criteria:

(1)Concomitant physical disease or brain organic disease; (2)Have used or are using any antidepressant or antipsychotic drugs in the past two weeks; (3)Remove emotional disorders caused by life factors such as alcohol or coffee, strong tea; (4)Women during pregnancy, lactation and menstruation; (5)Participating in other clinical trials within one month; (6)Suicidal.

研究实施时间:

Study execute time:

From 2019-03-19

To      2019-12-30

征募观察对象时间:

Recruiting time:

From 2019-05-08

To      2019-10-30

干预措施:

Interventions:

组别:

西药组

样本量:

18

Group:

western drugs group

Sample size:

干预措施:

帕罗西汀

干预措施代码:

Intervention:

paroxetine

Intervention code:

组别:

中西结合药物组

样本量:

18

Group:

chinese and western combined drugs group

Sample size:

干预措施:

四逆散联合帕罗西汀

干预措施代码:

Intervention:

Sini San combined with paroxetine

Intervention code:

样本总量 Total sample size : 36

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

陕西省

市(区县):

西安市

Country:

China

Province:

Shaanxi

City:

Xi’an

单位(医院):

陕西省中医医院

单位级别:

三甲医院

Institution/hospital:

Shaanxi Traditional Chinese Medicine Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

汉密尔顿抑郁量表

指标类型:

主要指标

Outcome:

Hamilton Depression Scale,HAMD

Type:

Primary indicator

测量时间点:

入组第1天、第30天及随访6周后评估

测量方法:

量表评分

Measure time point of outcome:

Evaluation was performed at day 1, day 30 and 6 weeks after enrollment

Measure method:

Rating scale

指标中文名:

暗光褪黑色素

指标类型:

主要指标

Outcome:

Dark melatonin

Type:

Primary indicator

测量时间点:

入组第1天及第30天检测;在上床睡觉时间前5小时开始每小时收集一次唾液。检测前10分钟内不能进食。

测量方法:

放免法检测

Measure time point of outcome:

Test on enrollment day 1 and day 30; Start collecting saliva hourly five hours before bedtime. Do not eat for 10 minutes before the test

Measure method:

radioimmunoassay

指标中文名:

时相角度差异

指标类型:

主要指标

Outcome:

PAD

Type:

Primary indicator

测量时间点:

入组第1天及第30天检测

测量方法:

多导睡眠图监测

Measure time point of outcome:

Test on enrollment day 1 and day 30

Measure method:

Polysomnography monitoring

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

唾液

组织:

Sample Name:

spit

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 65
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机信封 张瑞环医师:信封随机为错误随机表述方式,请说明何人使用何种方法(随机数字表?统计学软件?)产生随机序列。

Randomization Procedure (please state who generates the random number sequence and by what method):

Random envelope

盲法:

open

Blinding:

open

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2020年10月公开 在医院官网 http://www.sxatcm.com/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

data will be shared at http://www.sxatcm.com/ in October 2020

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

case record form will be used for data colledtion

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above